IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 18 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,258,839 | -55.8% | 1,250,000 | -51.9% | 0.04% | -46.6% |
| Q4 2022 | $2,848,625 | -31.9% | 2,600,000 | -36.6% | 0.07% | -20.7% |
| Q3 2022 | $4,185,000 | -52.6% | 4,100,000 | -49.4% | 0.09% | -53.8% |
| Q2 2022 | $8,829,000 | -8.3% | 8,100,000 | 0.0% | 0.20% | -20.7% |
| Q1 2022 | $9,627,000 | +3.8% | 8,100,000 | 0.0% | 0.25% | +5.9% |
| Q4 2021 | $9,275,000 | -5.2% | 8,100,000 | 0.0% | 0.24% | -15.4% |
| Q3 2021 | $9,780,000 | -39.6% | 8,100,000 | -40.0% | 0.28% | -38.5% |
| Q2 2021 | $16,193,000 | +24.2% | 13,500,000 | +17.4% | 0.46% | -3.0% |
| Q1 2021 | $13,038,000 | +54.4% | 11,500,000 | +53.3% | 0.47% | +58.4% |
| Q4 2020 | $8,444,000 | +57.5% | 7,500,000 | +36.4% | 0.30% | +52.6% |
| Q3 2020 | $5,360,000 | – | 5,500,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 69,285,732 | $54,302,494 | 2.70% |
| CAMDEN ASSET MANAGEMENT L P /CA | 50,071,000 | $48,664,005 | 1.81% |
| Boussard & Gavaudan Investment Management LLP | 6,577 | $6,483,091 | 0.76% |
| READYSTATE ASSET MANAGEMENT LP | 12,000,000 | $11,722,800 | 0.59% |
| BRAIDWELL LP | 15,500,000 | $15,141,950 | 0.48% |
| WOLVERINE ASSET MANAGEMENT LLC | 39,174,000 | $38,348,717 | 0.43% |
| CSS LLC/IL | 5,500,000 | $5,379,280 | 0.35% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,239,000 | $3,239,825 | 0.24% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,174,000 | $14,823,481 | 0.07% |
| Calamos Advisors LLC | 9,500,000 | $9,281,500 | 0.05% |